AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Drug Substance Manufacturing Market Procurement Intelligence Report | Drug Substance Manufacturing Price Trends, Drug Substance Manufacturing Suppliers, and Procurement Insights Now Available from SpendEdge

November 4, 2019
Drug Substance Manufacturing Market Procurement Intelligence Report | Drug Substance Manufacturing Price Trends, Drug Substance Manufacturing Suppliers, and Procurement Insights Now Available from SpendEdge
Drug Substance Manufacturing Market Procurement Intelligence Report | Drug Substance Manufacturing Price Trends, Drug Substance Manufacturing Suppliers, and Procurement Insights Now Available from SpendEdge

LONDON--(BUSINESS WIRE)--Nov 4, 2019--

SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Drug Substance Manufacturing Market - Procurement Intelligence Report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191104005458/en/

Global Drug Substance Manufacturing Market Procurement Intelligence Report (Graphic: Business Wire)

Uncertainty, spiraling expenditure, and risks are some of the antagonizing factors that will dominate the procurement scenario in the drug substance manufacturing market. With incidents like Johnson and Johnson opioid overdose fiasco, pertinent regulations are becoming more stringent and dynamic, adding to the difficulties of drug substance manufacturing suppliers. This will have a subsequent impact on procurement in terms of expenditure for buyers in the drug substance manufacturing market.

Read the free sampleof this drug substance manufacturing market procurement intelligence report to know what risks you may face in this market and the risk mitigation strategies you must adopt to sustain your business.

However, with adequate procurement strategies in place, buyers are investing in the drug substance manufacturing market which is evident in the projected spend growth of over 90 billion with the spend momentum accelerating at a CAGR of over 7%. This spend growth will be primarily attributed to the recent expiry of patent drugs that will trigger the demand growth of drug substance manufacturing suppliers. The rise in demand for specialty generics for the treatment of complex health conditions will also bring investments in this market.

Now get this complete drug substance manufacturing market procurement intelligence report in half the price or request a free demo of our web-based procurement platform to get regular and immediate updates on procurement strategies and price trends on a range of markets.

What are the drug substance manufacturing price trends that are driving the overall price structure in the global drug substance manufacturing market?

What are the scopes of optimizing procurement spend with these upward rising drug substance manufacturing price trends?

Factors that will contribute to these upward drug substance manufacturing price trends are inevitable and will prevail for the next five years. It has been concluded that to address such challenges, strategic selection of suppliers will help buyers to explore more opportunities to optimize their procurement spend in the drug substance manufacturing market.

Implement flexible production practices

Acquiring validation for new processes and configuration of the existing manufacturing lines for various products can be cumbersome and costly tasks. Engagement with suppliers who are known to implement flexible production practices will aid in the acceleration of these processes. The use of single-use systems (disposable systems) can reduce changeover time and minimize the consumption of clean water. In addition, flexible production practices provide dual benefits of reducing manufacturing costs and meeting sustainability goals.

Criteria for drug substance manufacturing suppliers selection is subject to change based on the day-to-day market outlook. Get the free sample of this market intelligence report to know the supplier selection and negotiation criteria that are based on the current drug substance manufacturing market performance across regions.

Adopt measures to enhance supply chain visibility

Buyers should leverage digital systems such as QMS, CRM, SCM, and ERP to gain better visibility during the entire supply chain. These digital systems, combined with analytical tools, can ensure a seamless flow of information and provide traceability and visibility across the supply chain. The use of these systems can help buyers track the parameters such as transaction history, environmental storage conditions, manufacturing location, among others.

Some of the key topics covered in this report are:

You may also like:

About SpendEdge:

SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions. To know more, https://www.spendedge.com/request-free-proposal

 

View source version on businesswire.com:https://www.businesswire.com/news/home/20191104005458/en/

CONTACT: SpendEdge

Anirban Choudhury

Marketing Manager

US: +1 630 984 7340

UK: +44 148 459 9299

https://www.spendedge.com/contact-us

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH OTHER MANUFACTURING MANUFACTURING

SOURCE: SpendEdge

Copyright Business Wire 2019.

PUB: 11/04/2019 08:03 AM/DISC: 11/04/2019 08:03 AM

http://www.businesswire.com/news/home/20191104005458/en